Immunoproliferative small intestinal disease associated with Campylobacter jejuni

被引:320
作者
Lecuit, M
Abachin, E
Martin, A
Poyart, C
Pochart, P
Suarez, F
Bengoufa, D
Feuillard, J
Lavergne, A
Gordon, JI
Berche, P
Guillevin, L
Lortholary, O
机构
[1] Hop Avicenne, Paris, France
[2] Inst Pasteur, Paris, France
[3] Hop Necker Enfants Malad, Paris, France
[4] Conservatoire Natl Arts & Metiers, Paris, France
[5] Hop St Louis, Paris, France
[6] Washington Univ, Sch Med, St Louis, MO USA
关键词
D O I
10.1056/NEJMoa031887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Immunoproliferative small intestinal disease (also known as alpha chain disease) is a form of lymphoma that arises in small intestinal mucosa-associated lymphoid tissue (MALT) and is associated with the expression of a monotypic truncated immunoglobulin (alpha) heavy chain without an associated light chain. Early-stage disease responds to antibiotics, suggesting a bacterial origin. We attempted to identify a causative agent. METHODS: We performed polymerase chain reaction (PCR), DNA sequencing, fluorescence in situ hybridization, and immunohistochemical studies on intestinal-biopsy specimens from a series of patients with immunoproliferative small intestinal disease. RESULTS: Analysis of frozen intestinal tissue obtained from an index patient with immunoproliferative small intestinal disease who had a dramatic response to antibiotics revealed the presence of Campylobacter jejuni. A follow-up retrospective analysis of archival intestinal-biopsy specimens disclosed campylobacter species in four of six additional patients with immunoproliferative small intestinal disease. CONCLUSIONS: These results indicate that campylobacter and immunoproliferative small intestinal disease are associated and that C. jejuni should be added to the growing list of human pathogens responsible for immunoproliferative states.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 38 条
  • [1] BOOSINGER TR, 1988, AM J VET RES, V49, P456
  • [2] Human campylobacteriosis in developing countries
    Coker, AO
    Isokpehi, RD
    Thomas, BN
    Amisu, KO
    Obi, CL
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (03) : 237 - 243
  • [3] EXPERIMENTAL-INFECTION OF GNOTOBIOTIC MICE WITH CAMPYLOBACTER-JEJUNI - COLONIZATION OF INTESTINE AND SPREAD TO LYMPHOID AND RETICULOENDOTHELIAL ORGANS
    FAUCHERE, JL
    VERON, M
    LELLOUCHTUBIANA, A
    PFISTER, A
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1985, 20 (02) : 215 - 224
  • [4] Regression of immunoproliferative smell intestinal disease after eradication of Helicobacter pylori
    Fischbach, W
    Tacke, W
    Greiner, A
    MullerHermelink, HK
    [J]. LANCET, 1997, 349 (9044) : 31 - 32
  • [5] GALIAN A, 1977, CANCER-AM CANCER SOC, V39, P2081, DOI 10.1002/1097-0142(197705)39:5<2081::AID-CNCR2820390526>3.0.CO
  • [6] 2-E
  • [7] PCR PRIMERS AND PROBES FOR THE 16S RIBOSOMAL-RNA GENE OF MOST SPECIES OF PATHOGENIC BACTERIA, INCLUDING BACTERIA FOUND IN CEREBROSPINAL-FLUID
    GREISEN, K
    LOEFFELHOLZ, M
    PUROHIT, A
    LEONG, D
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) : 335 - 351
  • [8] HARZIC M, 1985, GASTROEN CLIN BIOL, V9, P472
  • [9] THE RESPONSE OF CELLS FROM LOW-GRADE B-CELL GASTRIC LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TO HELICOBACTER-PYLORI
    HUSSELL, T
    ISAACSON, PG
    CRABTREE, JE
    SPENCER, J
    [J]. LANCET, 1993, 342 (8871) : 571 - 574
  • [10] ISAACSON P, 1983, CANCER, V52, P1410, DOI 10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO